The Central government has approved nine projects, including those from Siemens Healthcare and Wipro GE Healthcare for production-linked incentive (PLI) scheme in medical devices.

The PLI scheme has a total financial outlay of Rs 3,420 crore. The projects cleared belong to four broad categories such as cancer care/radiotherapy, radiology and imaging medical devices, anesthetics and cardio-respiratory medical devices and implants including implantable electronic devices.

The PLI scheme is expected to boost domestic manufacturing by attracting large-scale investment.

The setting up of these plants will lead to a total committed investment of Rs 729.63 crore by the companies and will generate over 2,300 jobs. The commercial production is projected to commence from April 2022 and the PLI disbursal by the government over the five years period will be up to a maximum of Rs 121 crore per applicant.